The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Maravai LifeSciences Holdings Inc shares valued at $100,625 were purchased by DeFord John A on Nov 12 ’24. At $5.75 per share, DeFord John A acquired 17,500 shares. The insider’s holdings grew to 70,046 shares worth approximately $0.34 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, HULL CARL purchased 175,000 shares, netting a total of over 987,000 in proceeds. Following the buying of shares at $5.64 each, the insider now holds 175,000 shares.
Before that, GTCR INVESTMENT XI LLC had sold 9,940,974 shares from its account. In a trade valued at $97,570,660, the Director traded Maravai LifeSciences Holdings Inc shares for $9.81 each. Upon closing the transaction, the insider’s holdings decreased to 9,940,974 shares, worth approximately $97.12 million.
As published in their initiating research note from Wolfe Research on November 14, 2024, Maravai LifeSciences Holdings Inc [MRVI] has been a Peer perform. Analysts at William Blair downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in early November. As of August 28, 2024, Wells Fargo has initiated its “an Overweight” rating for MRVI. Earlier on August 13, 2024, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for MRVI stock which previously was a “an Overweight”.
Analyzing MRVI Stock Performance
During the last five days, there has been a drop of approximately -14.39%. Over the course of the year, Maravai LifeSciences Holdings Inc shares have dropped approximately -26.41%. Shares of the company reached a 52-week high of $11.56 on 05/17/24 and a 52-week low of $4.28 on 11/18/24. A 50-day SMA is recorded $7.51, while a 200-day SMA reached $8.09. Nevertheless, trading volume fell to 1.64 million shares from 1.72 million shares the previous day.
Support And Resistance Levels for Maravai LifeSciences Holdings Inc (MRVI)
According to the 24-hour chart, there is a support level at 4.61, which, if violated, would cause prices to drop to 4.40. In the upper region, resistance lies at 5.04. The next price resistance is at 5.27. RSI (Relative Strength Index) is 31.92 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.39, which suggests the price will decrease in the coming days. Percent R is at 86.43%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
